ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 130 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,546,097 | $66,590,000 | 9.91% |
| RA Capital Management | 1,539,586 | $66,310,000 | 6.70% |
| SENZAR ASSET MANAGEMENT, LLC | 255,128 | $10,988,000 | 4.20% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 158,315 | $6,819,000 | 1.56% |
| Sarissa Capital Management LP | 105,000 | $4,522,000 | 1.54% |
| Ghost Tree Capital, LLC | 50,000 | $2,154,000 | 1.52% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 118,445 | $5,102,000 | 0.90% |
| WALL STREET ASSOCIATES | 219,200 | $9,441,000 | 0.81% |
| Granite Point Capital Management, L.P. | 25,000 | $1,077,000 | 0.74% |
| BAILARD, INC. | 91,500 | $3,941,000 | 0.61% |